New Products


Febit has launched a human cancer biochip for sequence capture with its HybSelect technology. The catalog chip includes 115 genes known to be associated with common types of cancer. The company also plans to launch a 2-megabase exon cancer biochip this summer and a 30-megabase biochip next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.